Liqun Wu

426 citations
13 papers · 117 indexed · h-index 6
Topics
Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Liver Disease Diagnosis and Treatment (4 papers)
Partner nations
China

In The Last Decade

Liqun Wu

13 papers receiving 116 citations

Peers

Liqun Wu
Comparison fields: 5 of 34
  • Hepatology 77
  • Surgery 55
  • Oncology 31
  • Epidemiology 29
  • Cancer Research 25
Replace Yoshiro Asahina with:
Yoshiro Asahina Japan
Zuojun Zhen China
Fengjiao Zhao China
Leszek Zając Poland
Riccardo Memeo Italy
Ryota Matsuki Japan
Shufa Yang China
Jiong-Jie Yu China
Ann‐Shing Lee China
Liqun Wu relative to Yoshiro Asahina Japan Yoshiro Asahina's profile →
Citations per field
00.5×1.5×
Yoshiro Asahina · 1×
Citations per year

Countries citing papers authored by Liqun Wu

Since Specialization
Citations

This map shows the geographic impact of Liqun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqun Wu more than expected).

Fields of papers citing papers by Liqun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqun Wu. The network helps show where Liqun Wu may publish in the future.

Co-authorship network of co-authors of Liqun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Liqun Wu. A scholar is included among the top collaborators of Liqun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqun Wu. Liqun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 2
2 3
3 15
4 17
5 16
6 23
7 5
8
Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma.
15
9 1
10 2
11 5
12
Efficacy of intra-tumor injection of Kang-Lai-Te in treating transplanted hepatoma in rats.
12
13
Effects of Shenbining on Apoptosis and Experssion of Bax and Bcl-2 in the Kidney of Mesangial Proliferative Glomerulonephritis
1

About Liqun Wu

Liqun Wu is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 13 papers that have together received 117 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Hepatology (77 citations), Cancer Research (25 citations) and Surgery (55 citations). Liqun Wu has collaborated with scholars based in China. Frequent co-authors include Zusen Wang, Zhiqiang Qu, Dingding Wang, Sheng Dong, Xin Wang, Weidong Guo, H. Lu, Bin Zhang, Jingyu Cao and Bing Han. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026